» Articles » PMID: 32104913

Designer Genetically Encoded Voltage-dependent Calcium Channel Inhibitors Inspired by RGK GTPases

Overview
Journal J Physiol
Specialty Physiology
Date 2020 Feb 28
PMID 32104913
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

High-voltage-activated calcium (Ca 1/Ca 2) channels translate action potentials into Ca influx in excitable cells to control essential biological processes that include; muscle contraction, synaptic transmission, hormone secretion and activity-dependent regulation of gene expression. Modulation of Ca 1/Ca 2 channel activity is a powerful mechanism to regulate physiology, and there are a host of intracellular signalling molecules that tune different aspects of Ca channel trafficking and gating for this purpose. Beyond normal physiological regulation, the diverse Ca channel modulatory mechanisms may potentially be co-opted or interfered with for therapeutic benefits. Ca 1/Ca 2 channels are potently inhibited by a four-member sub-family of Ras-like GTPases known as RGK (Rad, Rem, Rem2, Gem/Kir) proteins. Understanding the mechanisms by which RGK proteins inhibit Ca 1/Ca 2 channels has led to the development of novel genetically encoded Ca channel blockers with unique properties; including, chemo- and optogenetic control of channel activity, and blocking channels either on the basis of their subcellular localization or by targeting an auxiliary subunit. These genetically encoded Ca channel inhibitors have outstanding utility as enabling research tools and potential therapeutics.

Citing Articles

Electrically Active Biomaterials for Stimulation and Regeneration in Tissue Engineering.

Park J, Akbaba G, Sharma N, Das R, Vinikoor T, Liu Y J Biomed Mater Res A. 2025; 113(1):e37871.

PMID: 39806919 PMC: 11773453. DOI: 10.1002/jbm.a.37871.


Rad protein: An essential player in L-type Ca2+ channel localization and modulation in cardiomyocytes.

Kong C, Dries E J Gen Physiol. 2024; 156(10).

PMID: 39172109 PMC: 11344166. DOI: 10.1085/jgp.202413629.


Ion channel inhibition by targeted recruitment of NEDD4-2 with divalent nanobodies.

Morgenstern T, Darko-Boateng A, Afriyie E, Shanmugam S, Zhou X, Choudhury P bioRxiv. 2024; .

PMID: 38854018 PMC: 11160594. DOI: 10.1101/2024.05.28.596281.


Exploring the memory: existing activity-dependent tools to tag and manipulate engram cells.

Pang B, Wu X, Chen H, Yan Y, Du Z, Yu Z Front Cell Neurosci. 2024; 17:1279032.

PMID: 38259503 PMC: 10800721. DOI: 10.3389/fncel.2023.1279032.


Design and Applications of Genetically-Encoded Voltage-Dependent Calcium Channel Inhibitors.

Gavin A, Colecraft H Handb Exp Pharmacol. 2023; 279:139-155.

PMID: 37306815 DOI: 10.1007/164_2023_656.


References
1.
Dolphin A . Calcium channel auxiliary α2δ and β subunits: trafficking and one step beyond. Nat Rev Neurosci. 2012; 13(8):542-55. DOI: 10.1038/nrn3311. View

2.
Liu G, Papa A, Katchman A, Zakharov S, Roybal D, Hennessey J . Mechanism of adrenergic Ca1.2 stimulation revealed by proximity proteomics. Nature. 2020; 577(7792):695-700. PMC: 7018383. DOI: 10.1038/s41586-020-1947-z. View

3.
Berridge M, Lipp P, Bootman M . The versatility and universality of calcium signalling. Nat Rev Mol Cell Biol. 2001; 1(1):11-21. DOI: 10.1038/35036035. View

4.
Meissner M, Weissgerber P, Camacho Londono J, Prenen J, Link S, Ruppenthal S . Moderate calcium channel dysfunction in adult mice with inducible cardiomyocyte-specific excision of the cacnb2 gene. J Biol Chem. 2011; 286(18):15875-82. PMC: 3091197. DOI: 10.1074/jbc.M111.227819. View

5.
Makarewich C, Correll R, Gao H, Zhang H, Yang B, Berretta R . A caveolae-targeted L-type Ca²+ channel antagonist inhibits hypertrophic signaling without reducing cardiac contractility. Circ Res. 2012; 110(5):669-74. PMC: 3324037. DOI: 10.1161/CIRCRESAHA.111.264028. View